These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 2253250

  • 41. [Hyperuricemia and the kidney].
    Ichida K, Hikita M, Hosoya T.
    Nihon Rinsho; 1996 Dec; 54(12):3277-82. PubMed ID: 8976105
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Does renal impairment protect from gout?
    Youssef P, Brama T, York H, Pickard P, Stewart P, McGill N.
    J Rheumatol; 1995 Mar; 22(3):494-6. PubMed ID: 7783068
    [Abstract] [Full Text] [Related]

  • 45. [Allopurinol in the treatment of gout: initial results].
    Serre H, Simon L, Claustre J.
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):334-44. PubMed ID: 5701049
    [No Abstract] [Full Text] [Related]

  • 46. [Diagnostic value of hyperuricemia].
    Ryckewaert A.
    Presse Med (1893); 1968 Dec 14; 76(49):2319-22. PubMed ID: 5260909
    [No Abstract] [Full Text] [Related]

  • 47. [Treatment with allopurinol in gout and hyperuricemic renal disease].
    Hood B, Olander R.
    Lakartidningen; 1973 Mar 28; 70(13):1297-300. PubMed ID: 4699017
    [No Abstract] [Full Text] [Related]

  • 48. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P, Akkasilpa S, Deesomchok U.
    J Med Assoc Thai; 2002 Jun 28; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [Abstract] [Full Text] [Related]

  • 49. [Metabolic disorder of purine nucleotide in patients with renal disease].
    Hosoya T, Ohno I, Ichida K, Sakai O.
    Nihon Rinsho; 1996 Dec 28; 54(12):3354-9. PubMed ID: 8976119
    [Abstract] [Full Text] [Related]

  • 50. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I, Gresser U, Pellkofer T, Löffler W, Zöllner N.
    Z Rheumatol; 1989 Dec 28; 48(6):307-12. PubMed ID: 2623976
    [Abstract] [Full Text] [Related]

  • 51. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME, Johnson RJ, García-López E, Qureshi AR, Molinaei H, Carrero JJ, Heimbürger O, Bárány P, Axelsson J, Lindholm B, Stenvinkel P.
    Am J Kidney Dis; 2006 Nov 28; 48(5):761-71. PubMed ID: 17059995
    [Abstract] [Full Text] [Related]

  • 52. [Gout].
    Gröbner W, Zöllner N.
    Z Rheumatol; 2004 Feb 28; 63(1):2-9. PubMed ID: 14991273
    [Abstract] [Full Text] [Related]

  • 53. [Allopurinol treatment of hyperuricemia].
    Nissen NI, Paikin H.
    Nord Med; 1967 Oct 12; 78(41):1320-4. PubMed ID: 6054472
    [No Abstract] [Full Text] [Related]

  • 54. [Xanthinoxidase inhibitors in hyperuricemia and gout].
    Hajzok O, Hajzoková M, Urbánek T.
    Cas Lek Cesk; 1971 Nov 12; 110(46):1068-70. PubMed ID: 5133301
    [No Abstract] [Full Text] [Related]

  • 55. [Familial juvenile hyperuricemic nephropathy (FJHN)].
    Kudo E, Itakura M.
    Nihon Rinsho; 2008 Apr 12; 66(4):683-6. PubMed ID: 18409515
    [Abstract] [Full Text] [Related]

  • 56. Recessive X-linked hyperuricemia with gout and renal damage, normal activity of hypoxanthine phosphoribosyltransferase and resistance to azaguanine.
    Westberg NG, Rosén E, Waldenström J.
    Acta Med Scand; 1979 Apr 12; 205(3):163-7. PubMed ID: 425844
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.